This activity is specifically designed for laboratory technologists, managers and clinicians involved in the use of diagnostic test results to guide rational use of antimicrobials and in antimicrobial stewardship programmes.
At the end of the course, learners should be able to:
Define antimicrobial resistance (AMR), surveillance, and AMR surveillance
Provide the learner evidence why AMR surveillance is a critical component of the national, regional, and global AMR response
Describe who benefits from AMR surveillance
(Approximately 6–8 hours to complete Week 1)
The Global Burden of AMR
AMR Surveillance Systems
Models of AMR Surveillance
One Health Surveillance Systems
Genomic Surveillance
Who Benefits From Strengthened AMR Surveillance Systems
Dr. Carl Boodman, University of Manitoba, Canada
Professor Rosanna Peeling, London School of Hygiene & Tropical Medicine and International Diagnostics Centre, UK
Dr. Debi Boeras, Global Health Impact Group and Global Health Continuing Professional Development, US
Add your email to the mailing list to get the latest updates.
